RT Journal Article
SR Electronic
T1 An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 72
DO 10.1186/s40425-019-0541-0
VO 7
IS 1
A1 Clouthier, Derek L.
A1 Lien, Scott C.
A1 Yang, S. Y. Cindy
A1 Nguyen, Linh T.
A1 Manem, Venkata S. K.
A1 Gray, Diana
A1 Ryczko, Michael
A1 Razak, Albiruni R. A.
A1 Lewin, Jeremy
A1 Lheureux, Stephanie
A1 Colombo, Ilaria
A1 Bedard, Philippe L.
A1 Cescon, David
A1 Spreafico, Anna
A1 Butler, Marcus O.
A1 Hansen, Aaron R.
A1 Jang, Raymond W.
A1 Ghai, Sangeet
A1 Weinreb, Ilan
A1 Sotov, Valentin
A1 Gadalla, Ramy
A1 Noamani, Babak
A1 Guo, Mengdi
A1 Elston, Sawako
A1 Giesler, Amanda
A1 Hakgor, Sevan
A1 Jiang, Haiyan
A1 McGaha, Tracy
A1 Brooks, David G.
A1 Haibe-Kains, Benjamin
A1 Pugh, Trevor J.
A1 Ohashi, Pamela S.
A1 Siu, Lillian L.
YR 2019
UL http://jitc.bmj.com/content/7/1/72.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.